Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

3(42.9%)

Phase 2

1(14.3%)

7Total

Phase 4(3)

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06057181Recruiting

Helix Research Network

Role: collaborator

NCT06740266Not ApplicableRecruiting

The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families

Role: collaborator

NCT06511778Phase 4Recruiting

sTErnAl heMostasiS Trial

Role: lead

NCT05681182Phase 4Completed

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

Role: lead

NCT02299414Phase 4Completed

Chronic Hypertension and Pregnancy (CHAP) Project

Role: collaborator

NCT03635606Completed

GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients

Role: collaborator

NCT04757246Not ApplicableWithdrawn

RESPECT Heart Failure- RESpiratory Pattern Evaluation in Clinical Trials for HF

Role: lead

NCT00835861Phase 2Completed

Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes

Role: collaborator

NCT01443533Not ApplicableCompleted

Study of Birth Control Use After Childbirth

Role: lead

All 9 trials loaded